Replies to post #374749 on Innovation Pharmaceuticals Inc (IPIX)

[farrell90]

Synergy between Remdesivir and Brilacidin was predicted in the antiviral in vitro studies. Phase 2 confirmation of the synergy would be terrific.


Unfortunately it is likely only a few patients treated in the US received Remdesivir. The SOC antiviral in Russia is most likely Favipiravir.

Hopefully Brilacidin's anti-inflammatory effects will reduce pulmonary and other complications in the patients who are more ill.

We will see when the full results are reported.

GLTA Farrell